Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

"We are honored that Dr. Gilbert has recognized the revolutionary science at Calidi Biotherapeutics in both tumoral and glioblastoma cancer treatment. He joins other luminaries on our Medical Advisory Board who also believe in our stem-cell based therapy's potential to offer hope and better results for those with cancer," said Allan Camaisa, CEO of Calidi. Dr. Gilbert most recently served as the Chief of the Neuro-Oncology Branch at NIH from 2014 to 2024. Under Dr. Gilbert's leadership, his team of laborato ...